Skip Nav Destination
Committee on Substance Use and Prevention
AAP Policy authored by the Committee on Substance Use and Prevention
From the American Academy of Pediatrics Policy Statement
Brian P. Jenssen, MD, FAAP; Susan C. Walley, MD, FAAP; Rachel Boykan, MD, FAAP; Alice Little Caldwell, MD, MPH, IBCLC, FAAP; Deepa Camenga, MD, FAAP; SECTION ON NICOTINE AND TOBACCO PREVENTION AND TREATMENT; Judith A. Groner, MD, FAAP; Jyothi N. Marbin, MD, FAAP; Bryan Mih, MD, MPH, FAAP; Lily Rabinow, MD; Gregory H. Blake, MD; Karen S. Smith; James D. Baumberger, MPP; COMMITTEE ON SUBSTANCE USE AND PREVENTION; Lucien Gonzalez, MD, MS, FAAP; Rita Agarwal, MD, FAAP; Joanna Quigley, MD, FAAP; Kenneth Zoucha, MD, FAAP; Christine Kurien, DO; Rebecca Ba’Gah, MD, FAAP; Renee Jarrett, MPH
April 17 2023
From the American Academy of Pediatrics Technical Report
Brian P. Jenssen, MD, FAAP; Susan C. Walley, MD, FAAP; Rachel Boykan, MD, FAAP; Alice Little Caldwell, MD, MPH, IBCLC, FAAP; Deepa Camenga, MD, FAAP; SECTION ON NICOTINE AND TOBACCO PREVENTION AND TREATMENT, COMMITTEE ON SUBSTANCE USE AND PREVENTION; Judith A. Groner, MD, FAAP; Jyothi N. Marbin, MD, FAAP; Bryan Mih, MD, MPH, FAAP; Lily Rabinow, MD; Gregory H. Blake, MD; Karen S. Smith; James D. Baumberger, MPP; SECTION ON NICOTINE AND TOBACCO PREVENTION AND TREATMENT, COMMITTEE ON SUBSTANCE USE AND PREVENTION; Lucien Gonzalez, MD, MS, FAAP; Rita Agarwal, MD, FAAP; Joanna Quigley, MD, FAAP; Kenneth Zoucha, MD, FAAP; Leslie Walker-Harding, MD, FAAP; Christine Kurien, DO; Rebecca Ba’Gah, MD, FAAP; Renee Jarrett, MPH
April 17 2023
From the American Academy of Pediatrics Clinical Report
Brian P. Jenssen, MD, FAAP; Susan C. Walley, MD, FAAP; Rachel Boykan, MD, FAAP; Alice Little Caldwell, MD, MPH, IBCLC, FAAP; Deepa Camenga, MD, FAAP; SECTION ON NICOTINE AND TOBACCO PREVENTION AND TREATMENT; Susan C. Walley, MD, FAAP; Rachel Boykan, MD, FAAP; Judith A. Groner, MD, FAAP; Brian P. Jenssen, MD, FAAP; Jyothi N. Marbin, MD, FAAP; Bryan Mih, MD, MPH, FAAP; Alice Little Caldwell, MD, FAAP; Lily Rabinow, MD; Gregory H. Blake, MD; Karen S. Smith; James D. Baumberger, MPP; COMMITTEE ON SUBSTANCE USE AND PREVENTION; Lucien Gonzalez, MD, MS, FAAP; Rita Agarwal, MD, FAAP; Deepa R. Camenga, MD, MHS, FAAP; Joanna Quigley, MD, FAAP; Kenneth Zoucha, MD, FAAP; Leslie Walker-Harding, MD, FAAP; Christine Kurien, DO; Rebecca Ba’Gah, MD, FAAP; Renee Jarrett, MPH
April 17 2023
From the American Academy of Pediatrics Policy Statement
Deepa R. Camenga, MD, MHS, FAAP; Lawrence D. Hammer, MD, FAAP; the Committee on Substance Use and Prevention, and Committee on Child Health Financing
June 27 2022
From the American Academy of Pediatrics Policy Statements
Rachel H. Alinsky, MD, MPH, FAAP; Scott E. Hadland, MD, MPH, MS, FAAP; Joanna Quigley, MD, FAAP; Stephen W. Patrick, MD, MPH, MS, FAAP; COMMITTEE ON SUBSTANCE USE AND PREVENTION
May 23 2022
From the American Academy of Pediatrics Clinical Report
Stephen W. Patrick, MD, MPH, MS, FAAP; Wanda D. Barfield, MD, MPH, FAAP; Brenda B. Poindexter, MD, MS, FAAP; COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON SUBSTANCE USE AND PREVENTION; James Cummings, MD, FAAP; Ivan Hand, MD, FAAP; Ira Adams-Chapman, MD, MD, FAAP; Susan W. Aucott, MD, FAAP; Karen M. Puopolo, MD, FAAP; Jay P. Goldsmith, MD, FAAP; David Kaufman, MD, FAAP; Camilia Martin, MD, FAAP; Meredith Mowitz, MD, FAAP; Lucien Gonzalez, MD, MS, FAAP; Deepa R. Camenga, MD, MHS, FAAP; Joanna Quigley, MD, FAAP; Sheryl A. Ryan, MD, FAAP; Leslie Walker-Harding, MD, FAAP
November 01 2020
From the American Academy of Pediatrics Technical Report
Sheryl A. Ryan, MD; Patricia Kokotailo, MD; COMMITTEE ON SUBSTANCE USE AND PREVENTION; Deepa R. Camenga, MD; Stephen W. Patrick, MD; Jennifer Plumb, MD; Joanna Quigley, MD; Leslie Walker-Harding, MD
July 01 2019
From the American Academy of Pediatrics Policy Statement
Joanna Quigley, MD; COMMITTEE ON SUBSTANCE USE AND PREVENTION; Sheryl A. Ryan, MD; Deepa R. Camenga, MD; Stephen W. Patrick, MD; Jennifer Plumb, MD; Leslie Walker-Harding, MD
July 01 2019
From the American Academy of Pediatrics Clinical Report
Renee M. Turchi, MD; Vincent C. Smith, MD; COMMITTEE ON SUBSTANCE USE AND PREVENTION; COUNCIL ON CHILDREN WITH DISABILITIES; Sheryl A. Ryan, MD; Deepa R. Camenga, MD; Stephen W. Patrick, MD; Jennifer Plumb, MD; Joanna Quigley, MD; Leslie R. Walker-Harding, MD; Dennis Z. Kuo, MD; Susan Apkon, MD; Timothy J. Brei, MD; Lynn F. Davidson, MD; Beth Ellen Davis, MD; Kathryn A. Ellerbeck, MD; Susan L. Hyman, MD; Mary O’Connor Leppert, MD; Garey H. Noritz, MD; Christopher J. Stille, MD; Larry Yin, MD
October 01 2018
From the American Academy of Pediatrics Clinical Report
Sheryl A. Ryan, MD; Seth D. Ammerman, MD; Mary E. O’Connor, MD; COMMITTEE ON SUBSTANCE USE AND PREVENTION; SECTION ON BREASTFEEDING; Lucien Gonzalez, MD; Stephen W. Patrick, MD; Joanna Quigley, MD; Leslie R. Walker, MD; Joan Younger Meek, MD; IBCLC; Margreete Johnston, MD; Lisa Stellwagen, MD; Jennifer Thomas, MD; Julie Ware, MD
September 01 2018
From the American Academy of Pediatrics Clinical Report
Sheryl A. Ryan, MD; Seth D. Ammerman, MD; COMMITTEE ON SUBSTANCE USE AND PREVENTION; Pamela K. Gonzalez, MD; Stephen W. Patrick, MD; Joanna Quigley, MD; Leslie R. Walker, MD
March 01 2017
From the American Academy of Pediatrics Policy Statement
Stephen W. Patrick, MD; Davida M. Schiff, MD; COMMITTEE ON SUBSTANCE USE AND PREVENTION; Sheryl A. Ryan, MD; Joanna Quigley, MD; Pamela K. Gonzalez, MD; Leslie R. Walker, MD
March 01 2017
From the American Academy of Pediatrics Policy Statement
COMMITTEE ON SUBSTANCE USE AND PREVENTION; Sheryl A. Ryan, MD, FAAP; Pamela K. Gonzalez, MD, FAAP; Stephen W. Patrick, MD, MPH, MS, FAAP; Joanna Quigley, MD, FAAP; Lorena Siqueira, MD, MSPH, FAAP; Leslie R. Walker, MD, FAAP
September 01 2016
From the American Academy of Pediatrics Clinical Report
Vincent C. Smith, MD; Celeste R. Wilson, MD; COMMITTEE ON SUBSTANCE USE AND PREVENTION; Sheryl A. Ryan, MD; Pamela K. Gonzalez, MD; Stephen W. Patrick, MD; Joanna Quigley, MD; Lorena Siqueira, MD; Leslie R. Walker, MD
August 01 2016
From the American Academy of Pediatrics Policy Statement
COMMITTEE ON SUBSTANCE USE AND PREVENTION; Sharon J.L. Levy, MD; Janet F. Williams, MD; Sheryl A. Ryan, MD; Pamela K. Gonzalez, MD; Stephen W. Patrick, MD; Joanna Quigley, MD; Lorena Siqueira, MD; Vincent C. Smith, MD; Leslie R. Walker, MD
July 01 2016
From the American Academy of Pediatrics Clinical Report
Sharon J.L. Levy, MD; Janet F. Williams, MD; COMMITTEE ON SUBSTANCE USE AND PREVENTION; Sheryl A. Ryan, MD; Pamela K. Gonzalez, MD; Stephen W. Patrick, MD; Joanna Quigley, MD; Lorena Siqueira, MD; Vincent C. Smith, MD; Leslie R. Walker, MD
July 01 2016
From the American Academy of Pediatrics Clinical Report
Janet F. Williams, MD, FAAP; Vincent C. Smith, MD, MPH, FAAP; the COMMITTEE ON SUBSTANCE ABUSE
November 01 2015
From the American Academy of Pediatrics Clinical Report
Lorena Siqueira, MD; Vincent C. Smith, MD; COMMITTEE ON SUBSTANCE ABUSE; Sharon Levy, MD; Seth D. Ammerman, MD; Pamela K. Gonzalez, MD; Sheryl A. Ryan, MD; Lorena M. Siqueira, MD; Vincent C. Smith, MD
September 01 2015
From the American Academy of Pediatrics Technical Report
Sharon Levy, MD; Miriam Schizer, MD; COMMITTEE ON SUBSTANCE ABUSE; Seth D. Ammerman, MD; Pamela K. Gonzalez, MD; Sheryl A. Ryan, MD; Lorena M. Siqueira, MD; Vincent C. Smith, MD
April 01 2015
From the American Academy of Pediatrics Policy Statement
Sharon Levy, MD; Miriam Schizer, MD; COMMITTEE ON SUBSTANCE ABUSE; Seth D. Ammerman, MD; Pamela K. Gonzalez, MD; Sheryl A. Ryan, MD; Lorena M. Siqueira, MD; Vincent C. Smith, MD
April 01 2015